Launching PDGENEration to Advance Genetic Testing in Parkinson Disease: James Beck, PhD

Video

The chief scientific officer and senior vice president of the Parkinson’s Foundation discussed the organization’s initiative to advance genetic testing.

“The world of precision medicine is coming to Parkinson disease (PD), and the field is not ready. Meaning people with PD don't have ready access to genetic testing. It's not part of their standard of care. Clinicians don't know a person's genetic status. So, who's going to be able to participate in these trials? Who's going to be able to benefit from these therapies when no one knows whether they have a genetic form of PD or not?”

As precision medicine and gene therapies start to be explored and tested in more fields, a greater knowledge base of patient genetics is needed. Genetic testing needs to become part of the standard of care to enable future genetic medicine treatment or participation in clinical trials research. One such field is Parkinson disease (PD), many patients with which have not been genetically tested and whose genetic status remains unknown.

In response to this issue, the Parkinson’s Foundation has launched PDGENEration (NCT04057794), their initiative to offer genetic counseling and testing to people with PD. Participation in the study is available at-home or in-person in sites across the US to people with PD.

CGTLive spoke with James Beck, PhD, chief scientific officer and senior vice president, Parkinson’s Foundation, to learn more about the launch of PDGENEration and the need for genetic testing in people with PD. Neurologists seeking more information about PD GENEration can visit PDGENEration.com or email [email protected]for questions about enrollment.

Related Videos
George Tachas, PhD
Alexandra Gomez-Arteaga, MD
Pietro Genovese, PhD, the principal investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorder Center
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital
M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Frederick “Eric” Arnold, PhD
Genovefa (Zenia) Papanicolaou, MD, an infectious diseases specialist at Memorial Sloan Kettering Cancer Center
Jeffrey Chamberlain, PhD, on Exciting New Research at MDA 2024
Alan Beggs, PhD, on Challenges in Therapeutic Development for Rare Diseases
© 2024 MJH Life Sciences

All rights reserved.